Thank you for sharing!

Your article was successfully shared with the contacts you provided.

BOSTON-The biotech market is showing increased activity, but that has not yet translated into lower vacancies in Cambridge or suburban Boston, according to a recently released report by Richards Barry Joyce & Partners.

The report, titled “bioSTATus Q3 2003″ indicates that there is growth in private and public funding for the state’s biotech companies, as well as an increase in the number of clinical trials being performed by firms in the state. According to the firm’s Massachusetts Clinical Growth Index, the overall number of clinical trials being performed by biotech companies with a presence in Massachusetts has increased to 144 in the third quarter of 2003, from 120 in the first quarter of this year. In Phase II trials, there has been an increase of 35% over levels in the first quarter of the year.

The biotech market consists of 10.9 million sf in the Greater Boston area. While the city, which has the smallest market at two million sf had a vacancy rate of only 2.5% this past quarter according to the report, Cambridge’s rate was up to 18% in its 5.4-million-sf market as was the suburb’s in its 3.5-million-sf market. In the first quarter of 2001, Cambridge’s biotech vacancy rate was at 13% while the suburb’s was at 17% in the first quarter of the year.

The figures that tell the other part of the biotech story are the likely lab conversions. The report notes that Boston has no space in this category, while Cambridge has about 1.4 million sf and the suburbs have 340,000 sf. But the report notes that Cambridge’s figure demonstrates a slowdown in conversion of space and will not continue to impact vacancy rates. The high cost of conversion and the increase in sublease space in Cambridge have convinced many property owners not to undergo the process.

Other trends that the report emphasizes include the fact that biotech companies are continuing to demand aggressive concessions from landlords, resulting in extensions of the deal cycle. Also, large biotech companies are struggling to dispose of sublease space, which is a major contributing factor in the reduction of rent rates in all sub-markets. Cambridge’s rental rates have dropped from the high $50s per sf to the low to mid $40s per sf. The suburbs are at the low $20s per sf to the mid $30s per sf depending upon the location. The report adds that while Cambridge remains the region’s biotech epicenter, Boston and suburban markets are gaining in prominence. The city has recently begun a campaign to attract biotech companies and the report notes that a number of biotech companies are looking to establish corporate campuses in the suburbs.

“The improvement in capital markets, increase in clinical trials and greater focus by government officials to attract and retain biotech companies all give reason to be optimistic as we look towards 2004,” says Robert Richards, president of Richards Barry Joyce & Partners.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?

Dig Deeper



Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.